Myomo (MYO) Return on Capital Employed (QoQ) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1,045.00 |
| Jun 30, 2025 | -1,370.00 |
| Mar 31, 2025 | 1,295.00 |
| Dec 31, 2024 | 5,817.00 |
| Sep 30, 2024 | 501.00 |
| Jun 30, 2024 | -112.00 |
| Mar 31, 2024 | -1,494.00 |
| Dec 31, 2023 | 582.00 |
| Sep 30, 2023 | 1,069.00 |
| Jun 30, 2023 | 3,633.00 |
| Mar 31, 2023 | 891.00 |
| Dec 31, 2022 | -2,066.00 |
| Sep 30, 2022 | -3,696.00 |
| Jun 30, 2022 | -1,369.00 |
| Mar 31, 2022 | 80.00 |
| Dec 31, 2021 | -412.00 |
| Sep 30, 2021 | -607.00 |
| Jun 30, 2021 | 1,232.00 |
| Mar 31, 2021 | 1,336.00 |
| Dec 31, 2020 | 954.00 |
| Sep 30, 2020 | 407.00 |
| Jun 30, 2020 | 6,187.00 |
| Mar 31, 2020 | 27,749.00 |
| Dec 31, 2019 | -24,553.00 |
| Sep 30, 2019 | -6,461.00 |
| Jun 30, 2019 | 405.00 |
| Mar 31, 2019 | 349.00 |
| Dec 31, 2018 | -4,127.00 |
| Sep 30, 2018 | -2,880.00 |
| Jun 30, 2018 | -1,009.00 |
| Mar 31, 2018 | 2,064.00 |
| Dec 31, 2017 | 3,929.00 |